Jae‐Weon Kim

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

PDGF stimulation of inositol phospholipid hydrolysis requires PLC-γ1 phosphorylation on tyrosine residues 783 and 1254

Ha Kun Kim, Jae‐Weon Kim, Asher Zilberstein et al. · Cell · 1991 · 572 citations

Proteinlipid Interaction, Signal Transduction, Inositol Phospholipid Hydrolysis +13

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

Philipp Harter, Jalid Sehouli, Domenica Lorusso et al. · New England Journal of Medicine · 2019 · 571 citations · Full text

Regulation of Phospholipase C-γ1 by Profilin and Tyrosine Phosphorylation

Pascal J. Goldschmidt‐Clermont, Jae‐Weon Kim, Laura M. Machesky et al. · Science · 1991 · 532 citations

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text